March 03, 2015 4:42 AM ET


Company Overview of Elixir Pharmaceuticals, Inc.

Executive Profile

Kenneth Greenberg M.D., MBA

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Kenneth Greenberg, Ken serves as Principal of MPM BioVentures IV L.P and MPM Capital. At McKinsey & Co., Dr. Greenberg worked extensively on research and development and corporate strategy for life science companies and on buyout transactions for private equity clients. Prior to joining McKinsey, he advised biotechnology and medical device companies as an investment banker at Merrill Lynch. Dr. Greenberg also worked at HealthMarket, where he oversaw disease management ...

Corporate Headquarters

300 Putnam Avenue
Cambridge, Massachusetts 02139

United States

Phone: 617-995-7000
Fax: 617-995-7050

Board Members Memberships



Duke University
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elixir Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at